Preparation,Characterization and Drug Release Behavior of 5-Fluorouracil Loaded Carboxylic Poly(ε-caprolactone) Nanoparticles

In this paper, 5-Fluorouracil (5-FU) loaded carboxylic poly(ε-caprolactone) nanoparticles have been prepared by emulsification/solvent evaporation o/w method, and the drug release behaviors of 5-FU were investigated. The novel carboxylic poly (ε-caprolactone) (P(CL-OPD)-mal) was synthesized via conjugation of maleic anhydride to sodium borohydride (NaBH₄) reduced poly(ε-caprolactone-co -4- carbonyl -ε-caprolactone) (P(CL-OPD)), while P(CL-OPD) was synthesized in bulk by ring-opening polymerization of ε-caprolactone and 4-carbonyl-ε-caprolactone (OPD) with stannous octoate as a catalyst. Their structures were confirmed by ¹HNMR, FT-IR and GPC. Dynamic light scattering (DLS), transmission electron microscopy (TEM), zeta potential measurements were used for nanoparticle characterization. TEM and DLS showed the nanoparticles were with spherical shape and uniform size distribution (mean diameter 70～100 nm), respectively. Zeta potential analysis revealed that the nanoparticles had an increased negative surface with the increase of carboxyl group concentration. UV spectroscopy was adopted to study the entrapment and release behaviour. The maximum 5-FU loading efficiency was 14.39% with the entrapment efficiency be 42%. In vitro release studies were performed in PBS at 37°C. Results of the study showed that the release behavior can be well-controlled, and the balanced release was up to 96 h. P(CL-OPD)-mal nanoparticles would provide increased benefit in biomedical and pharmaceutical applications.     

功能化纳米粒子作为药物载体的研究

将合成的含有羧基侧基官能团的己内酯类聚合物, 用溶剂挥发与超声乳化相结合的方法制备成表面可供修饰的纳米粒子. 利用扫描电镜(SEM)研究了纳米粒子在水溶液中的形态. 使用5-氟脲嘧啶(5-FU)作为模型药物制备了载药纳米粒子, 利用紫外分光光度计法、差示扫描量热法(DSC)、X射线衍射法(XRD)研究了纳米粒子的载药及释放性能. 研究表明, 载药纳米粒子可以控制5-FU的释放速率. 释放时间可持续至96 h 以上, 符合Higuchi 动力学方程.     

Modified PLA nano in situ gel: a potential ophthalmic drug delivery system

A novel nano in situ gel forming system of 5-Fluorouracil (5-FU) was investigated for its potential use for conjunctival/corneal squamous cell carcinoma (CCSC). The study was conducted in two steps, in the first step PLA nanoparticles were prepared and characterized; in the second step the drug loaded PLA nanoparticles were dispersed in sodium alginate solution yielding the modified nano in situ system, which were evaluated in rabbit eye. Size and morphology of prepared PLA particles were verified by using dynamic light scattering (DLS), atomic force microscope (AFM) and scanning electron microscope (SEM). In vitro and in vivo study of free 5-FU, PLA nanoparticles and modified nano in situ system were conducted in simulated tear fluid and in rabbit eye respectively. PLA nanoparticles were in size range of 128-194 nm with spherical shape and smooth surface with narrow size distribution. No polymer drug interaction was found as confirmed by FTIR, NMR and DSC. XRD of PLA nanoparticles confirmed that 5-FU was present in the crystalline state. In vitro experiments indicated a diffusion controlled release of 5-FU from both PLA nanoparticles and modified nano in situ system with high burst effect. Modified nano in situ gel system (MNS) significantly increased the Cmax and AUC0-8 in aqueous humor as compared to 5-FU solution and PLA nanoparticles. Higher 5-FU level in aqueous humor was possibly because of increased retention time of gel matrix-embedded drug loaded nanoparticles. Overall results showed the potential of MNS for ophthalmic delivery in the therapy of CCSC.     

Synthesis and characterization of novel biodegradable folate conjugated polyurethanes

In order to obtain targeting polyurethane micelle drug carriers, a series of biodegradable folate conjugated polyurethanes (FPUs) were synthesized using poly(ethylene glycol) (PEG) and poly(ε-caprolactone) (PCL) as soft segments, L-lysine ethyl ester diisocyanate (LDI) and 1,3-propanediol (PDO) as hard segments, and folic acid-ethylenediamine conjugate (FA-EDA) as an end-capping reagent. The resultant FPUs were fully characterized by (1)H NMR, Fourier-transform infrared (FTIR) spectroscopy, ultraviolet spectrophotometry (UV), gel permeation chromatography (GPC), and differential scanning calorimetry (DSC). These polymers can self-assemble into micelles in aqueous solutions confirmed by dynamic light scattering (DLS), pyrene fluorescence probe techniques, and transmission electron microscopy (TEM). The results indicated that the bulk structures and micellar properties of the prepared polyurethanes could be controlled by varying the PEG content in the soft segments. The present work provides a facile approach to prepare amphiphilic multiblock copolymers with tumor targeting moiety, which is a good candidate as biodegradable carriers for active intracellular drug delivery.     

Adsorption of asphaltenes from heavy oil onto in situ prepared NiO nanoparticles

In this study, a series of membranes with different amino group densities were prepared to investigate the surface properties of the novel poly(γ-amino-ε-caprolactone-co-ε-caprolactone) (NPCL) copolymer synthesized by our laboratory. Meanwhile, the human mesenchymal stem cells' (hMSCs) behavior on those membranes was examined. The molecular characteristics of the NPCL copolymers were characterized by nuclear magnetic resonance (NMR), size exclusion chromatography (SEC), and differential scanning calorimetry (DSC). Surface properties of membranes were characterized by water contact angle analysis, X-ray photoelectron spectroscopy analysis (XPS), and atomic force microscopy (AFM). It was found that the incorporation of amino groups to the poly(ε-caprolactone) (PCL) backbone resulted in an augmented wettability, a decreased crystallinity, and also an increased surface roughness on the NPCL membranes. In vitro cell experiments showed a significant enhancement in hMSCs' adhesion, proliferation, and osteogenic differentiation on NPCL membranes compared with virgin PCL membrane, and demonstrated that surface properties of membrane played an important role in tailoring cell behavior.     

A self-expandable C-shaped 3D printing tracheal stent for combinatorial controlled paclitaxel release and tracheal support

Current tracheal stents palliatively relieve malignant tracheal stenosis but cannot treat the tumor, resulting in the occurrence of restenosis due to tumor progressive over-growth. Moreover, the stents block the entire tracheal mucosa contact with them and thus prevent mucus/sputum discharge, causing an airway blockage. In order to overcome those shortcomings, we study a novel self-expandable C-shaped tracheal stent loaded with paclitaxel (PTX), which consists of an inner poly (ε-caprolactone) layer, a middle Fe₃O₄ magnetic nanoparticles loaded poly (ε-caprolactone) layer and an outer PTX-loaded ethylene-vinyl acetate copolymer layer containing phase-change 1-hexadecanol. The C-shaped tracheal stents are easily fabricated on a roller by using a self-made specific three-dimensional printer. It is found that the stents present unidirectional PTX release, good self-expanding and appropriate trachea supporting properties, and generate heat to raise temperature under an alternating magnetic field, which facilitates temperature-responsive PTX release and permeation in tracheal tissue. The stents have good biosafety in rabbits and keep airway patency for the investigated period (1 month) without the occurrence of mucus/sputum blockage after implantation in rabbit trachea. This study provides a scientific basis for the development of novel self-expandable C-shaped tracheal stents with combinatorial tracheal support and local chemotherapy.     

Preparation of 5-Fluorouracii Loaded Polylactide-co-glycolide-co-methoxy Poly(ethylene glycol) (PLGA-mPEG) Nanoparticles via High Speed Shearing

5-Fluorouracil(5-FU) loaded nanoparticles(NPs) were prepared by a high speed shearing double emulsion method with polylactide-co-glycolide-co-methoxy poly(ethylene glycol)(PLGA-mPEG) as loading material.The prepared NPs possess a negative zeta potential and their loading efficiency is about 15%(mass fraction).The result of in vitro release shows that the release behavior of 5-FU from NPs is coincident with Zero-level release from the second day.     

双亲支链梳形共聚物的合成及其自乳化负载药物性能

通过可逆加成-断裂链转移(RAFT)聚合制备出聚甲基丙烯酸缩水甘油酯(PGMA),经过叠氮钠与PGMA环氧基团的反应引入叠氮基和羟基,然后依次通过端炔基聚乙二醇(PEG-alk)与叠氮基的点击反应,己内酯(CL)在羟基存在下的开环聚合反应,获得双亲支链梳形共聚物(PGMA-g-PEG/PCL)。利用该梳形共聚物的两亲性,在氯仿-水混合体系中,进行自乳化高效负载阿霉素(DOX),得到负载DOX的纳米粒子。利用核磁共振氢谱、红外光谱和凝胶渗透色谱确认了最终产物及其前体聚合物的结构。利用动态光散射、紫外可见分光光度计和扫描电镜研究该载药粒子在pH为7.0和5.0的水溶液中的释放。结果表明:该纳米粒子平均粒径约为100nm,该粒子能有效释放DOX,在酸性条件下释放速率加快,且伴随PCL的降解。     

Preparation of 5-Fluorouracil Loaded Polylactide-co-glycolide-co-methoxy Poly（ethylene glycol） （PLGA-mPEG） Nanoparticles via High Speed Shearing

5-Fluorouracil（5-FU） loaded nanoparticles（NPs） were prepared by a high speed shearing double emulsion method with polylactide-co-glycolide-co-methoxy poly（ethylene glycol）（PLGA-mPEG） as loading material. The prepared NPs possess a negative zeta potential and their loading efficiency is about 15%（mass fraction）. The result of in vitro release shows that the release behavior of 5-FU from NPs is coincident with Zero-level release from the second day.     

Synthesis and barrier properties of poly(ε-caprolactone)-layered silicate nanocomposites

A new polymer-ceramic nanocomposite has been synthesized consisting of well-dispersed, two-dimensional layers of an organically modified mica-type silicate (MTS) within a degradable poly(ε-caprolactone) matrix. A protonated amino acid derivative of MTS was used to promote delamination/dispersion of the host layers and initiate ring-opening polymerization of ε-caprolactone monomer, resulting in poly(ε-caprolactone) chains that are ionically bound to the silicate layers. The polymer chains can be released from the silicate surface by a reverse ion-exchange reaction and were shown to be spectroscopically similar to pure poly(ε-caprolactone). Thick films of the polymer nanocomposite exhibit a significant reduction in water vapor permeability that shows a linear dependence on silicate content. The permeability of nanocomposite containing as low as 4.8% silicate by volume was reduced by nearly an order of magnitude compared to pure poly(ε-caprolactone). © 1995 John Wiley & Sons, Inc.     

Zein supports scaffolding capacity toward mammalian cells and bactericidal and antiadhesive properties on poly(ε-caprolactone)/zein electrospun fibers

Studies investigate the electrospinnability of poly(ε-caprolactone)/protein blends to produce fibers for tissue engineering applications. However, no reports show that zein can improve the scaffolding capacity toward stem cells and promote antiadhesive and bactericidal properties to the poly(ε-caprolactone)/zein fibers. We create fibers with average diameters ranging from 200 to 400 nm from the electrospinning of poly(ε-caprolactone)/protein mixtures. Poly(ε-caprolactone)/zein blends are electrospinnable at zein concentration between 20 and 40 wt% in a 70/30 formic acid/acetic acid mixture. Water contact angle measurements indicate that zein increases fiber hydrophilicity. The water contact angle decreases from 118° (pure poly(ε-caprolactone) fiber) to 73° for the scaffold containing 40 wt% zein. The zein (40 wt%) significantly increases Young's modulus from 260 MPa (pure poly(ε-caprolactone) fibers) to 980 MPa (poly(ε-caprolactone)/zein fibers) with no substantial influence on elongation at break (ε ≥ 125%) and tensile strength (≥0.040 MPa). The electrospun scaffolds containing zein also promote cell adhesion, proliferation, and spreading of adipose-derived human mesenchymal stem cells for at least 7 days of culture. The zein on poly(ε-caprolactone)/zein fibers can prevent the attachment and proliferation of Escherichia coli and Staphylococcus aureus. We propose these materials for wound healing and skin repair.     

Length scale effect of PCL-PB-PCL on the light scattering and dynamics of network

The effect of length scale of triblock oil-soluble polymer (poly (ε-caprolactone)–poly butadiene-poly (ε-caprolactone)) (PCL-PB-PCL) on the properties of a water-in-oil (W/O) droplet microemulsion (R ~ 5.5 nm) has been studied as a function of the amount of added telechelic polymer. Small-angle X-ray scattering (SAXS) measurements show that the size of the droplets is not affected by the polymer addition but it induces attractive interactions at low concentration and repulsive ones at high polymer content. Measurements of the diffusion coefficient by dynamic light scattering (DLS) show different relaxations in mixed systems. The fast diffusion coefficient increases with increase in polymer concentration. At higher polymer content, the network formation leads to an additional slow relaxation mode in DLS that can be related to the formation of clusters of microemulsion droplets interconnected by the polymer. The collective diffusion of slow relaxations decreases with increase of polymer concentrations.     

Development of poly(ε-caprolactone-co-l-lactide) and poly(ε-caprolactone-co-δ-valerolactone) as new degradable binder used for antifouling paint

Copolyesters containing ε-caprolactone and l-lactide or ε-caprolactone and δ-valerolactone at different compositions were synthesized by using tetrabutoxytitane Ti(OBu)₄ at high temperature in bulk. A series of copolyesters were prepared by varying the compositions of both comonomers. These copolymers were characterized by using ¹H NMR, ¹³C NMR, gel permeation chromatography (GPC), differential scanning calorimetry (DSC) and MALDI-TOF mass spectrometry. ¹³C NMR analysis gave an insight on their microstructure. Structural parameters of the copolymers were obtained by calculating the triad sequence fractions. Poly(ε-caprolactone-co-l-lactide) has a more alternate structure than poly(ε-caprolactone-co-δ-valerolactone). The potential use of these copolyesters in antifouling coatings was examined because of their solubility in aromatic solvent and their hydration and hydrolytic degradation. Paints based on these new degradable binders had a good antifouling activity in Atlantic Ocean (France).     

同载基因和药物的超微载体粒子的制备及体外评价

以聚乳酸_乙醇酸共聚物 (PLGA)和自行制备的O_羧甲基壳聚糖 (O_CMC)为原料 ,以 5_氟尿嘧啶 (5 Fu)为抗癌药物模型 ,以反义EGFR(表皮生长因子受体 )为基因药物模型 ,构建与评价了同载抗癌药物与基因的复合功能纳米药物载体系统。同载超微粒子的平均粒径为 2 5 8 7nm ,粒径分布指数为 0 14 2 ,粒子表面 ξ电位为 - 10 6 7eV。同载超微粒子在PBS中的释药行为研究表明 :超微粒子中 5_FU和基因均具有零级缓慢释放特性。体外肿瘤细胞存活率实验和免疫组化实验均证实同载超微粒子能高效抑制TJ90 5人脑胶质瘤细胞的增殖。最后用荧光共聚焦显微镜动态监测了超微粒子进入瘤细胞的转染过程 ,发现粒子可在不同时间内进入细胞浆和细胞核。     

Sacrificial template-directed fabrication of superparamagnetic polymer microcontainers for pH-activated controlled release of Daunorubicin

Magnetic pH-sensitive microcontainers were produced by a four-step process. The first step involves the synthesis of citrate-modified magnetic nanoparticles via the coprecipitation method. The second step consists of the encapsulation of magnetic nanoparticles in non-cross-linked poly(methacrylic acid) (PMAA) microspheres through distillation precipitation polymerization, resulting in a core/shell structure. The third step concerns the formation of a poly(N,N'-methylenebis(acrylamide)-co-mathacrylic acid) (P(MBAAm-co-MAA)) layer on the surface of magnetic PMAA microspheres by second distillation precipitation polymerization in order to produce a trilayer hybrid microsphere. The last step deals with the removal of PMAA layer in ethanol and formation of a stable P(MBAAm-co-MAA) microcontainer with magnetic nanoparticles entrapped inside the formed cavity. This process is simple and leads to the formation of superparamagnetic pH-sensitive microcontainers. The structure and properties of the magnetic microcontainers were investigated by X-ray diffraction (XRD), transmission electron microscopy (TEM), scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), vibrating sample magnetometry (VSM), and dynamic light scattering (DLS) to determine the functionalities of the hybrid structure. The magnetic pH-sensitive microcontainers were loaded with Daunorubicin and tested with respect to release rate at different pH values in order to evaluate their functionality as controlled release system.     

Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study

The aim of this investigation was to develop 5-fluorouracil (5-FU) loaded chitosan nanoparticles (CH-DNPs) for ophthalmic delivery. CH-DNPs were fabricated by ionotropic gelation mechanism using chitosan (CH) and a polyanion (TPP). The nanoparticles were smooth and spherical, confirmed by scanning electron microscopy (SEM) and atomic force microscope (AFM). CH/TPP mass ratio and TPP significantly changed the particles size morphology and encapsulation efficiency. The nanoparticles size ranged from approximately 114 to 192 nm and had a positive zeta potential (30±4 mV). The encapsulation efficiency, loading capacity and recovery of DNPs were 8.12-34.32%, 3.14-15.24% and 24.22 to 67% respectively. Physical characterization was done by Fourier transform infrared (FT-IR) and X-ray diffraction (XRD). No interaction was observed in between drug and polymer and crystallinity of drug was not changed in drug loaded nanoparticles. In-vitro release study of DNPs showed diffusion controlled release. Bioavailability study of batch CS9 was studied in rabbit eye and compare to 5-FU solution. 5-FU level was significantly higher in aqueous humor of rabbit eye. Ocular tolerance was studied in the eye of New Zealand rabbits and tested formulation was non-irritant with no sign of inflammation.     

β-cyclodextrin/alginate nanoparticles encapsulated 5-fluorouracil as an effective and safe anticancer drug delivery system

Although 5-Fluorouracil (5-FU) is one of the most frequently used cytotoxic chemotherapy drugs in the treatment of cancer, it possesses a short biological half-life and toxic side effects against normal healthy cells. In this work, β-cyclodextrin/alginate (β-CD/Alg) nanoparticles loaded with 5-fluorouracil (5-FU) were prepared to evaluate release properties and bioactivity in different pH media. Stable nanocomposites with the best loading efficiency (36%) and encapsulation efficiency (90%) were successfully fabricated. The size of the nanocomposite solution was determined via dynamic light scattering (DLS) to be in the range 30–120 nm with a mean size of 70 nm, while TEM images showed the particle size of the nanocomposite to be in the range 30–80 nm with a mean size of 50 nm. The release profile of 5-FU in a simulated gastric fluid (pH 1.2) was much lower than in a simulated colorectal fluid (pH 7.4). The release behaviour of 5-FU from the nanocomposite was confirmed by the change in morphology in the pH media. A cytotoxicity assay indicated that the nanocomposite is an effective delivery system for 5-FU with strong antiproliferative activity against MCF-7 cells and negligible effects on normal healthy cells.     

由高效双键易位闭环反应合成环状聚ε-己内酯

研究了合成环状大分子的一种新方法,即借助活性开环聚合反应和高效双键易位闭环反应(RCMR)合成环状聚ε-己内酯.首先,ε-己内酯在环状引发剂2,2-二丁基-2-锡-1,3-二氧环庚烷(DSDOP)的作用下,进行活性开环聚合反应,获得双羟基封端的聚ε-己内酯(PCLOH);然后,在对甲苯磺酸、1,3-二环己基碳二亚胺(DCC)和4-二甲氨基吡啶(DMAP)的作用下,将PCLOH与3-丁烯酸反应转化为双烯丙基封端的聚ε-己内酯(allylPCL);在Grubbs催化剂(Cl2(Cy3)2Ru CHPh)的作用下,将allylPCL经RCMR环化成环状聚ε-己内酯,并采用SEC,NMR,TGA以及DSC等技术对聚合物的结构和热力学性能进行了表征,SEC和黏度表征结果显示环状聚ε-己内酯具有较小的动态力学体积,TGA和DSC表征结果显示环状聚ε-己内酯的热分解温度较其线型前体高13℃,环化的结果使其熔点和结晶度下降.结果表明allylPCL在较稀(2.5×10-5mol/L)体系中,借助Grubbs催化剂进行的RCMR分子内环化反应效率高,环化产物无需进一步分离提纯.     

PLGA/O-CMC载药纳米粒子的体外释药行为研究

本文以聚乳酸-乙醇酸共聚物(PLGA)和自行制备的O-羧甲基壳聚糖(O-CMC)为原料,以5-氟尿嘧啶(5-FU)为抗癌药物模型,采用自身设计的改良复乳法制备了载药纳米微粒。微粒平均粒径为98.5nm,粒径分布指数为0.192,粒子表面∈电位为61．48eV,载药率高达18．9％,包封率为86％。然后用SEM动态监测载药纳米粒子降解过程中表面形貌的变化,并连续追踪粒子降解过程中的质量损失和降解介质的pH变化。载药纳米粒子在PBS中的释药行为研究表明：(1)前12h的释药动力学符合Huguchi方程,具有一级释放特性;(2)在20天内的释药动力学符合零级释放特性。     

结构规整的高密度两亲性接枝聚合物刷的合成及其自组装研究

大分子单体通过两种可控聚合方法, 即开环易位聚合(ROMP)和原子转移自由基聚合(ATRP)的联用, 合成一种新型两亲性接枝聚合物刷. 具有高环张力的降冰片烯单侧链大分子单体norbornene-graft-poly(ε-caprolactone)/Br (PCL- NBE-Br)首先进行ROMP反应, 生成聚合物主链, 每个单体单元上含有一条PCL链和一个溴官能团; 然后用含溴的ROMP聚合物poly(norbornene)-graft-poly(ε-caprolactone)/Br (PCL-PNBE-Br)作为大分子引发剂引发单体2-(dimethyl- amino)ethyl methacrylate)的ATRP反应, 生成结构明确的高密度两亲性接枝聚合物刷poly(norbornene)-graft-poly(ε- caprolactone)/poly(2-(dimethylamino)ethyl methacrylate) (PCL-PNBE-PDMAEMA), 其主链每个单体单元上均含有一条疏水性PCL接枝链和一条亲水性PDMAEMA接枝链. 最后, 研究此类高密度两亲性接枝聚合物刷的自组装行为, 用动态激光光散射(DLS)研究其在混合溶剂(THF/H2O)中的胶束行为, 考察胶束溶液的浓度以及不同长度的亲水性接枝链对胶束尺寸的影响; 利用透射电镜(TEM)观察胶束为球形, 具有类似线团或草莓状的形态.